-
-
-
-
-
-
-
Neurogene Highlights Data at ASGCT Meeting Supporting Therapeutic Rationale for ICV Delivery Method in CNS-targeted Gene Therapy
-
-
-
-
-
-
-
Neurogene Reports Third Quarter 2025 Financial Results and Highlights Recent Updates
-
-
-
-
-
-
-
Neurogene Reports First Quarter 2024 Financial Results and Highlights Recent Updates
-
-
-
-
-
-
-
Neoleukin Therapeutics (NLTX) to Merge with Neurogene
1,185,382 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

